Single‐cell mass cytometry adapted to measurements of the cell cycle

Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytomet...

Full description

Saved in:
Bibliographic Details
Published inCytometry. Part A Vol. 81A; no. 7; pp. 552 - 566
Main Authors Behbehani, Gregory K., Bendall, Sean C., Clutter, Matthew R., Fantl, Wendy J., Nolan, Garry P.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry
AbstractList Mass cytometry is a recently introduced technology that utilizes transition element isotope-tagged antibodies for protein detection on a single-cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5-iodo-2-deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage.
Abstract Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry
Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry
Mass cytometry is a recently introduced technology that utilizes transition element isotope-tagged antibodies for protein detection on a single-cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5-iodo-2-deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. copyright 2012 International Society for Advancement of Cytometry
Author Fantl, Wendy J.
Nolan, Garry P.
Clutter, Matthew R.
Behbehani, Gregory K.
Bendall, Sean C.
Author_xml – sequence: 1
  givenname: Gregory K.
  surname: Behbehani
  fullname: Behbehani, Gregory K.
– sequence: 2
  givenname: Sean C.
  surname: Bendall
  fullname: Bendall, Sean C.
– sequence: 3
  givenname: Matthew R.
  surname: Clutter
  fullname: Clutter, Matthew R.
– sequence: 4
  givenname: Wendy J.
  surname: Fantl
  fullname: Fantl, Wendy J.
– sequence: 5
  givenname: Garry P.
  surname: Nolan
  fullname: Nolan, Garry P.
  email: gnolan@stanford.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22693166$$D View this record in MEDLINE/PubMed
BookMark eNqFkLtOwzAUQC1URB-wMSOPDKQ4duwkI6ooIFXqQBmYLMe-hqA8SpwIZeMT-Ea-hKQpHWHytXR8dH2maFSUBSB07pO5Twi91m1dztWcUhLyIzTxOadeEDMyOsyUjtHUuTdCGCeMnqAxpSJmvhATtHxMi5cMvj-_NGQZzpVzuDfmUFctVkZtazC4LnEOyjUV5FDUDpcW16-Ad090qzM4RcdWZQ7O9ucMPS1vN4t7b7W-e1jcrDwdhJR7yk-4iJThLNYi4CYwMTMaTGRVnDAmrE4YNzShCiDUgkSRFcRaDmHS3QOfzdDl4N1W5XsDrpZ56vo1VAFl46Tf_VawkEbsf5RQSnkXJ-jQqwHVVelcBVZuqzRXVdtBso8s-yRSyV3kDr_Ym5skB3OAf6t2ABuAjzSD9k-ZXDxv1oP2B8sxi6o
CitedBy_id crossref_primary_10_1002_1873_3468_12712
crossref_primary_10_1038_s41385_018_0047_y
crossref_primary_10_1038_s41467_018_07333_4
crossref_primary_10_1016_j_bbapap_2015_01_008
crossref_primary_10_1002_cyto_a_22894
crossref_primary_10_1038_s41418_020_0498_z
crossref_primary_10_26508_lsa_201900554
crossref_primary_10_1002_cyto_a_23621
crossref_primary_10_1002_cyto_a_22498
crossref_primary_10_1038_s41596_018_0016_7
crossref_primary_10_3390_ijms160818878
crossref_primary_10_1016_j_leukres_2020_106404
crossref_primary_10_1038_s41587_020_0651_8
crossref_primary_10_1038_s41598_021_91816_w
crossref_primary_10_1016_j_csbj_2020_03_024
crossref_primary_10_1038_s41593_022_01181_8
crossref_primary_10_1186_s12865_017_0192_1
crossref_primary_10_1002_adhm_202201846
crossref_primary_10_1002_ctm2_206
crossref_primary_10_1002_cyto_a_22778
crossref_primary_10_1016_j_trac_2023_117257
crossref_primary_10_1038_ncb3507
crossref_primary_10_1002_eji_201646632
crossref_primary_10_1002_cyto_a_22648
crossref_primary_10_1097_ACI_0000000000000319
crossref_primary_10_1021_acs_analchem_2c04165
crossref_primary_10_1038_s41467_022_34653_3
crossref_primary_10_2139_ssrn_3869896
crossref_primary_10_1039_D3AN00370A
crossref_primary_10_1158_1541_7786_MCR_22_0109
crossref_primary_10_1189_jlb_1112571
crossref_primary_10_1002_adhm_202202422
crossref_primary_10_1016_j_cell_2017_07_024
crossref_primary_10_1093_mtomcs_mfac085
crossref_primary_10_1002_adma_202008297
crossref_primary_10_1038_s41467_019_09128_7
crossref_primary_10_1073_pnas_2115567119
crossref_primary_10_1002_cpim_31
crossref_primary_10_1021_acs_chemrev_2c00350
crossref_primary_10_1002_cyto_a_23283
crossref_primary_10_1007_s00216_017_0310_1
crossref_primary_10_1002_cyto_a_23960
crossref_primary_10_1002_cyto_a_24016
crossref_primary_10_1016_j_tig_2015_07_003
crossref_primary_10_1111_febs_14730
crossref_primary_10_1021_acs_analchem_0c03908
crossref_primary_10_1038_s41598_022_04842_7
crossref_primary_10_1016_j_celrep_2023_113293
crossref_primary_10_1021_acsnanoscienceau_3c00001
crossref_primary_10_1038_s41592_020_0737_8
crossref_primary_10_1016_j_aca_2014_02_033
crossref_primary_10_1038_s41418_018_0167_7
crossref_primary_10_1016_j_omton_2024_200820
crossref_primary_10_1158_2159_8290_CD_15_0298
crossref_primary_10_1016_j_cll_2021_03_008
crossref_primary_10_1021_jacs_6b12822
crossref_primary_10_1038_nbt_2283
crossref_primary_10_1038_s41392_023_01380_0
crossref_primary_10_1124_dmd_114_060798
crossref_primary_10_1189_jlb_6RU0115_020R
crossref_primary_10_3390_cells12162045
crossref_primary_10_1016_j_tcb_2022_01_012
crossref_primary_10_1002_cpcy_25
crossref_primary_10_1002_cyto_a_23793
crossref_primary_10_1049_iet_syb_2016_0016
crossref_primary_10_1093_infdis_jiac500
crossref_primary_10_1016_j_copbio_2014_07_004
crossref_primary_10_1002_anie_201405233
crossref_primary_10_1002_cyto_a_23799
crossref_primary_10_1039_C9EN01104H
crossref_primary_10_1002_mas_21391
crossref_primary_10_1074_mcp_R119_001790
crossref_primary_10_1021_acs_analchem_8b02790
crossref_primary_10_1177_2472630319834057
crossref_primary_10_15252_emmm_202013144
crossref_primary_10_1371_journal_pcbi_1003806
crossref_primary_10_1002_cyto_a_22573
crossref_primary_10_1016_j_cell_2016_04_019
crossref_primary_10_3109_10408363_2012_738808
crossref_primary_10_1038_s41467_020_17186_5
crossref_primary_10_1039_C7LC00546F
crossref_primary_10_1002_cyto_a_22336
crossref_primary_10_1016_j_vaccine_2015_06_117
crossref_primary_10_1021_acs_bioconjchem_9b00559
crossref_primary_10_1002_eji_201970107
crossref_primary_10_1039_D0JA00194E
crossref_primary_10_1016_j_biologicals_2013_08_006
crossref_primary_10_1016_j_cels_2018_02_010
crossref_primary_10_1002_ange_201405233
crossref_primary_10_3389_fimmu_2020_578176
crossref_primary_10_1016_j_stem_2015_01_015
crossref_primary_10_1002_1873_3468_12231
crossref_primary_10_1021_acs_analchem_9b00198
crossref_primary_10_1186_s40425_016_0107_3
crossref_primary_10_15252_msb_202110402
crossref_primary_10_1111_cpr_12050
crossref_primary_10_1186_s13045_017_0401_7
crossref_primary_10_1371_journal_pone_0079987
crossref_primary_10_1021_acs_analchem_5b04749
crossref_primary_10_1080_15476286_2017_1327510
crossref_primary_10_1021_acs_analchem_9b04970
crossref_primary_10_1039_D2NR06020E
crossref_primary_10_1002_cyto_b_21860
crossref_primary_10_1016_j_crmeth_2022_100238
crossref_primary_10_1021_acs_analchem_2c00795
crossref_primary_10_1002_cyto_a_22285
crossref_primary_10_1038_s41598_017_03610_2
crossref_primary_10_1002_cyto_a_22323
crossref_primary_10_1126_sciadv_ade9238
crossref_primary_10_1002_cyto_a_23495
crossref_primary_10_1016_j_crmeth_2022_100236
crossref_primary_10_1016_j_isci_2022_105826
crossref_primary_10_1186_s13059_014_0525_9
crossref_primary_10_1038_s41584_019_0338_z
crossref_primary_10_1007_s00018_023_04772_1
crossref_primary_10_1371_journal_pcbi_1003365
crossref_primary_10_1007_s00216_016_0075_y
crossref_primary_10_1039_C4LC00795F
crossref_primary_10_1016_j_cell_2023_11_005
crossref_primary_10_1002_cyto_b_21502
crossref_primary_10_1016_j_coi_2013_07_004
crossref_primary_10_1186_s12915_021_01138_6
crossref_primary_10_1039_C7AN01346A
crossref_primary_10_1002_cyto_a_23521
crossref_primary_10_1002_cyto_a_24852
crossref_primary_10_1016_j_cll_2017_07_010
crossref_primary_10_1016_j_advms_2019_12_001
crossref_primary_10_1152_ajpheart_00514_2021
crossref_primary_10_1038_s41596_021_00603_4
crossref_primary_10_1002_cyto_a_22799
crossref_primary_10_1002_cbic_202000369
crossref_primary_10_1126_scitranslmed_aac5722
crossref_primary_10_1073_pnas_1806695115
crossref_primary_10_1002_cyto_a_23929
crossref_primary_10_1038_s41556_020_0474_3
crossref_primary_10_1021_acs_analchem_2c01509
crossref_primary_10_1038_nprot_2016_089
crossref_primary_10_1074_jbc_RA119_009061
crossref_primary_10_1039_D3JA00412K
crossref_primary_10_1038_s41598_022_16616_2
crossref_primary_10_1007_s00216_014_8143_7
crossref_primary_10_1002_cyto_a_23630
crossref_primary_10_1038_s41467_018_03005_5
crossref_primary_10_1002_smll_201907674
crossref_primary_10_1021_acs_analchem_0c03560
crossref_primary_10_1002_cyto_a_22268
crossref_primary_10_3389_fimmu_2018_01672
crossref_primary_10_1038_s41598_018_25000_y
crossref_primary_10_1371_journal_pone_0131722
crossref_primary_10_1016_j_cbpa_2020_12_005
Cites_doi 10.1038/nbt.1991
10.1016/S0092-8674(04)00300-9
10.1002/cyto.a.20003
10.1016/j.jim.2005.09.020
10.1002/0471142956.cy0724s28
10.1007/978-1-61737-950-5_11
10.1002/0471142956.cy0703s30
10.1084/jem.20050967
10.1039/b710510j
10.1101/sqb.2008.73.031
10.1021/ac702128m
10.1073/pnas.96.6.3120
10.1369/jhc.4A6285.2004
10.1186/1471-2105-10-106
10.1126/science.1198704
10.1182/blood.V68.6.1185.1185
10.2353/ajpath.2006.060312
10.1002/0471142956.cy1017s53
10.1158/1078-0432.CCR-09-0787
10.1182/blood.V56.3.361.361
10.1021/ac901049w
10.1002/cyto.a.20252
10.1046/j.1356-9597.2001.00498.x
10.1002/(SICI)1097-0320(19960901)25:1<1::AID-CYTO1>3.0.CO;2-N
10.1182/blood.V44.1.1.1
10.1089/scd.2007.0017
10.1182/blood-2005-06-2325
ContentType Journal Article
Copyright Copyright © 2012 International Society for Advancement of Cytometry
Copyright © 2012 International Society for Advancement of Cytometry.
Copyright_xml – notice: Copyright © 2012 International Society for Advancement of Cytometry
– notice: Copyright © 2012 International Society for Advancement of Cytometry.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
8FD
FR3
P64
RC3
DOI 10.1002/cyto.a.22075
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE
CrossRef

Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1552-4930
EndPage 566
ExternalDocumentID 10_1002_cyto_a_22075
22693166
CYTO22075
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Rachford and Carlota A. Harris Endowed Professorship
– fundername: Stanford Cancer Center
– fundername: Bill and Melinda Gates Foundation
  funderid: GF12141‐137101
– fundername: NIH/NCI
  funderid: U19 AI057229; P01 CA034233; HHSN272200700038C; 1R01CA130826; NCI RFA CA 09‐011; NHLBI‐HV‐10‐05(2); CIRM DR1‐01477; RB2‐01592
– fundername: European Commission
  funderid: HEALTH.2010.1.2‐1
– fundername: NCI NIH HHS
  grantid: R01 CA130826
– fundername: NHLBI NIH HHS
  grantid: HHSN268201000034C
– fundername: NCI NIH HHS
  grantid: U54 CA149145
– fundername: NIAID NIH HHS
  grantid: T32 AI007290
– fundername: NIAID NIH HHS
  grantid: HHSN272200700038C
– fundername: NCI NIH HHS
  grantid: P01 CA034233
– fundername: NCI NIH HHS
  grantid: CA034233
– fundername: NCI NIH HHS
  grantid: CA 09011
– fundername: NIAID NIH HHS
  grantid: U19 AI057229
– fundername: NCI NIH HHS
  grantid: 1R01CA130826
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
24P
2WC
31~
33P
3SF
4.4
4ZD
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABPVW
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CO8
CS3
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRSTM
DU5
E3Z
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
P2P
P2W
P2X
P4D
Q.N
QB0
QRW
R.K
RNS
ROL
RWI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBKPD
WIH
WIK
WIN
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XV2
ZZTAW
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
8FD
FR3
P64
RC3
ID FETCH-LOGICAL-c4725-a1b568ad539c645d4d93dced8fa9b336fcb35d2b2aee7c6088f60ff5e7be7c413
IEDL.DBID DR2
ISSN 1552-4922
IngestDate Sat Aug 17 02:22:15 EDT 2024
Sat Aug 17 01:09:49 EDT 2024
Fri Aug 23 02:59:15 EDT 2024
Sat Sep 28 07:55:28 EDT 2024
Sat Aug 24 00:42:11 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License Copyright © 2012 International Society for Advancement of Cytometry.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4725-a1b568ad539c645d4d93dced8fa9b336fcb35d2b2aee7c6088f60ff5e7be7c413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://europepmc.org/articles/pmc3667754?pdf=render
PMID 22693166
PQID 1022259224
PQPubID 23479
PageCount 15
ParticipantIDs proquest_miscellaneous_1492637283
proquest_miscellaneous_1022259224
crossref_primary_10_1002_cyto_a_22075
pubmed_primary_22693166
wiley_primary_10_1002_cyto_a_22075_CYTO22075
PublicationCentury 2000
PublicationDate July 2012
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 07
  year: 2012
  text: July 2012
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: United States
PublicationTitle Cytometry. Part A
PublicationTitleAlternate Cytometry A
PublicationYear 2012
Publisher Wiley Subscription Services, Inc., A Wiley Company
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
References 2006; 69A
2011; 699
2010; 16
2009; 81
2011
2010
1997; 25
2002; 7
2004
2008; 73
2011; 332
2004; 58A
2007; 16
2004; 52
1974; 44
2011; 108
2009; 10
2006; 308
2004; 60B
2005; 202
1986; 68
1980; 56
2008; 23
1999; 96
1996; 25
2006; 107
2011; 29
2004; 117
2008; 80
2006; 169
1994; 54
21757645 - Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12845-50
10077647 - Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3120-5
20145169 - Clin Cancer Res. 2010 Feb 15;16(4):1094-9
16336974 - J Immunol Methods. 2006 Jan 20;308(1-2):68-76
16538653 - Cytometry A. 2006 Apr;69(4):249-59
19122859 - J Anal At Spectrom. 2008;23(4):463-469
21116986 - Methods Mol Biol. 2011;699:229-49
15084261 - Cell. 2004 Apr 16;117(2):239-51
16877336 - Am J Pathol. 2006 Aug;169(2):338-46
18318509 - Anal Chem. 2008 Apr 1;80(7):2539-47
21551058 - Science. 2011 May 6;332(6030):687-96
15221864 - Cytometry B Clin Cytom. 2004 Jul;60(1):1-13
4525505 - Blood. 1974 Jul;44(1):1-18
3535923 - Blood. 1986 Dec;68(6):1185-95
9197332 - Exp Hematol. 1997 Jun;25(6):530-5
11856369 - Genes Cells. 2002 Jan;7(1):11-7
19022770 - Cold Spring Harb Symp Quant Biol. 2008;73:439-49
16234360 - Blood. 2006 Feb 1;107(3):1166-73
8875049 - Cytometry. 1996 Sep 1;25(1):1-13
14994216 - Cytometry A. 2004 Mar;58(1):21-32
16330818 - J Exp Med. 2005 Dec 5;202(11):1599-611
18770805 - Curr Protoc Cytom. 2004 Nov;Chapter 7:Unit 7.3
17999593 - Stem Cells Dev. 2007 Oct;16(5):707-17
6931620 - Blood. 1980 Sep;56(3):361-7
19358741 - BMC Bioinformatics. 2009;10:106
8044772 - Cancer Res. 1994 Aug 15;54(16):4285-8
19601617 - Anal Chem. 2009 Aug 15;81(16):6813-22
18770801 - Curr Protoc Cytom. 2004 May;Chapter 7:Unit 7.24
15505345 - J Histochem Cytochem. 2004 Nov;52(11):1503-9
22692796 - Cytometry A. 2012 Jul;81(7):546-8
22046573 - Bone Marrow Res. 2011;2011:950934
20578106 - Curr Protoc Cytom. 2010 Jul;Chapter 10:Unit10.17
21964415 - Nat Biotechnol. 2011 Oct;29(10):886-91
e_1_2_9_30_2
e_1_2_9_12_2
e_1_2_9_11_2
Moore MA (e_1_2_9_8_2) 1974; 44
Raza A (e_1_2_9_9_2) 1997; 25
Preisler H (e_1_2_9_33_2) 1980; 56
e_1_2_9_14_2
e_1_2_9_16_2
e_1_2_9_15_2
e_1_2_9_18_2
e_1_2_9_17_2
Pearce DJ (e_1_2_9_10_2) 2006; 107
e_1_2_9_19_2
Griffin J (e_1_2_9_7_2) 1986; 68
van Lochem EG (e_1_2_9_13_2) 2004; 60
e_1_2_9_21_2
e_1_2_9_20_2
e_1_2_9_23_2
e_1_2_9_22_2
Gong J (e_1_2_9_28_2) 1994; 54
e_1_2_9_6_2
e_1_2_9_5_2
e_1_2_9_4_2
e_1_2_9_3_2
e_1_2_9_2_2
Passegue E (e_1_2_9_31_2) 2005; 202
Head DR (e_1_2_9_32_2) 2011
e_1_2_9_25_2
e_1_2_9_24_2
e_1_2_9_26_2
(e_1_2_9_27_2) 2011; 108
e_1_2_9_29_2
References_xml – volume: 308
  start-page: 68–76
  year: 2006
  article-title: Multiple cellular antigen detection by ICP‐MS
  publication-title: J Immunol Methods
– volume: 7
  start-page: 11–17
  year: 2002
  article-title: Aurora‐B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation
  publication-title: Genes to Cells
– volume: 10
  start-page: 106
  year: 2009
  article-title: flowCore: A bioconductor package for high throughput flow cytometry
  publication-title: BMC Bioinformatics
– year: 2010
  article-title: Web‐based analysis and publication of flow cytometry experiments
  publication-title: Curr Protoc Cytom
– volume: 60B
  start-page: 1–13
  year: 2004
  article-title: Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts
  publication-title: Cytometry Part B: Clinical Cytometry
– start-page: 2011
  year: 2011
  article-title: Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis
  publication-title: Bone Marrow Res
– volume: 80
  start-page: 2539–2547
  year: 2008
  article-title: Study of cell antigens and intracellular DNA by identification of element‐containing labels and metallointercalators using inductively coupled plasma mass spectrometry
  publication-title: Anal Chem
– volume: 52
  start-page: 1503–1509
  year: 2004
  article-title: Characterization of a monoclonal antibody, HTA28, recognizing a histone H3 phosphorylation site as a useful marker of M‐phase cells
  publication-title: J Histochem Cytochem
– volume: 108
  start-page: 12845–12850
  year: 2011
  article-title: Asymmetric cancer cell division regulated by AKT
  publication-title: Proc Natl Acad Sci
– volume: 69A
  start-page: 249–259
  year: 2006
  article-title: Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry
  publication-title: Cytometry Part A
– volume: 58A
  start-page: 21–32
  year: 2004
  article-title: Cytometry of the cell cycle: Cycling through history
  publication-title: Cytometry Part A
– volume: 96
  start-page: 3120–3125
  year: 1999
  article-title: In vivo proliferation and cell cycle kinetics of long‐term self‐renewing hematopoietic stem cells
  publication-title: Proc. Natl. Acad. Sci. USA
– year: 2004
  article-title: Detection of mitotic cells
  publication-title: Curr Protoc Cytom
– volume: 16
  start-page: 1094–1099
  year: 2010
  article-title: Targeting the RB‐pathway in cancer therapy
  publication-title: Clin Cancer Res
– volume: 56
  start-page: 361–367
  year: 1980
  article-title: Prediction of response to chemotherapy in acute myelocytic leukemia
  publication-title: Blood
– volume: 699
  start-page: 229–249
  year: 2011
  article-title: Multiparameter cell cycle analysis
  publication-title: Methods in molecular biology
– volume: 117
  start-page: 239–251
  year: 2004
  article-title: Cyclin C/Cdk3 promotes Rb‐dependent G0 Exit
  publication-title: Cell
– volume: 25
  start-page: 1–13
  year: 1996
  article-title: Cytometry of cyclin proteins
  publication-title: Cytometry
– volume: 25
  start-page: 530
  year: 1997
  article-title: Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo‐ and/or bromodeoxyuridine
  publication-title: Exp Hematol
– volume: 68
  start-page: 1185–1195
  year: 1986
  article-title: Clonogenic cells in acute myeloblastic leukemia
  publication-title: Blood
– volume: 44
  start-page: 1–18
  year: 1974
  article-title: Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics
  publication-title: Blood
– volume: 107
  start-page: 1166–1173
  year: 2006
  article-title: AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML
  publication-title: Blood
– volume: 23
  start-page: 463–469
  year: 2008
  article-title: Development of analytical methods for multiplex bio‐assay with inductively coupled plasma mass spectrometry
  publication-title: J Anal At Spectrom
– volume: 29
  start-page: 886–891
  year: 2011
  article-title: Extracting a cellular hierarchy from high‐dimensional cytometry data with SPADE
  publication-title: Nat Biotech
– volume: 54
  start-page: 4285–4288
  year: 1994
  article-title: Unscheduled expression of Cyclin B1 and Cyclin E in several leukemic and solid tumor cell lines
  publication-title: Cancer Res
– year: 2004
  article-title: Differential staining of DNA and RNA
  publication-title: Curr Protoc Cytom
– volume: 169
  start-page: 338–346
  year: 2006
  article-title: Hematopoietic stem cells: The paradigmatic tissue‐specific stem cell
  publication-title: Am J Pathol
– volume: 73
  start-page: 439–449
  year: 2008
  article-title: Establishment of a normal hematopoietic and leukemia stem cell hierarchy
  publication-title: Cold Spring Harb Symp Quant Biol
– volume: 81
  start-page: 6813–6822
  year: 2009
  article-title: Mass cytometry: Technique for real time single cell multitarget immunoassay based on inductively coupled plasma time‐of‐flight mass spectrometry
  publication-title: Anal Chem
– volume: 332
  start-page: 687–696
  year: 2011
  article-title: Single‐cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum
  publication-title: Science
– volume: 202
  start-page: 1599–1611
  year: 2005
  article-title: Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates
  publication-title: J Exp Med
– volume: 16
  start-page: 707–717
  year: 2007
  article-title: The effect of bleeding on hematopoietic stem cell cycling and self‐renewal
  publication-title: Stem Cells Dev
– ident: e_1_2_9_6_2
  doi: 10.1038/nbt.1991
– volume: 54
  start-page: 4285–4288
  year: 1994
  ident: e_1_2_9_28_2
  article-title: Unscheduled expression of Cyclin B1 and Cyclin E in several leukemic and solid tumor cell lines
  publication-title: Cancer Res
  contributor:
    fullname: Gong J
– ident: e_1_2_9_16_2
  doi: 10.1016/S0092-8674(04)00300-9
– ident: e_1_2_9_25_2
  doi: 10.1002/cyto.a.20003
– ident: e_1_2_9_2_2
  doi: 10.1016/j.jim.2005.09.020
– ident: e_1_2_9_18_2
  doi: 10.1002/0471142956.cy0724s28
– ident: e_1_2_9_19_2
  doi: 10.1007/978-1-61737-950-5_11
– ident: e_1_2_9_22_2
  doi: 10.1002/0471142956.cy0703s30
– volume: 202
  start-page: 1599–1611
  year: 2005
  ident: e_1_2_9_31_2
  article-title: Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates
  publication-title: J Exp Med
  doi: 10.1084/jem.20050967
  contributor:
    fullname: Passegue E
– ident: e_1_2_9_3_2
  doi: 10.1039/b710510j
– ident: e_1_2_9_29_2
  doi: 10.1101/sqb.2008.73.031
– ident: e_1_2_9_14_2
  doi: 10.1021/ac702128m
– ident: e_1_2_9_30_2
  doi: 10.1073/pnas.96.6.3120
– volume: 60
  start-page: 1–13
  year: 2004
  ident: e_1_2_9_13_2
  article-title: Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts
  publication-title: Cytometry Part B: Clinical Cytometry
  contributor:
    fullname: van Lochem EG
– ident: e_1_2_9_21_2
  doi: 10.1369/jhc.4A6285.2004
– ident: e_1_2_9_11_2
  doi: 10.1186/1471-2105-10-106
– ident: e_1_2_9_5_2
  doi: 10.1126/science.1198704
– volume: 68
  start-page: 1185–1195
  year: 1986
  ident: e_1_2_9_7_2
  article-title: Clonogenic cells in acute myeloblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood.V68.6.1185.1185
  contributor:
    fullname: Griffin J
– ident: e_1_2_9_24_2
  doi: 10.2353/ajpath.2006.060312
– start-page: 2011
  year: 2011
  ident: e_1_2_9_32_2
  article-title: Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis
  publication-title: Bone Marrow Res
  contributor:
    fullname: Head DR
– ident: e_1_2_9_12_2
  doi: 10.1002/0471142956.cy1017s53
– ident: e_1_2_9_26_2
  doi: 10.1158/1078-0432.CCR-09-0787
– volume: 56
  start-page: 361–367
  year: 1980
  ident: e_1_2_9_33_2
  article-title: Prediction of response to chemotherapy in acute myelocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood.V56.3.361.361
  contributor:
    fullname: Preisler H
– ident: e_1_2_9_4_2
  doi: 10.1021/ac901049w
– ident: e_1_2_9_15_2
  doi: 10.1002/cyto.a.20252
– ident: e_1_2_9_20_2
  doi: 10.1046/j.1356-9597.2001.00498.x
– ident: e_1_2_9_17_2
  doi: 10.1002/(SICI)1097-0320(19960901)25:1<1::AID-CYTO1>3.0.CO;2-N
– volume: 108
  start-page: 12845–12850
  year: 2011
  ident: e_1_2_9_27_2
  article-title: Asymmetric cancer cell division regulated by AKT
  publication-title: Proc Natl Acad Sci
– volume: 44
  start-page: 1–18
  year: 1974
  ident: e_1_2_9_8_2
  article-title: Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics
  publication-title: Blood
  doi: 10.1182/blood.V44.1.1.1
  contributor:
    fullname: Moore MA
– ident: e_1_2_9_23_2
  doi: 10.1089/scd.2007.0017
– volume: 107
  start-page: 1166–1173
  year: 2006
  ident: e_1_2_9_10_2
  article-title: AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML
  publication-title: Blood
  doi: 10.1182/blood-2005-06-2325
  contributor:
    fullname: Pearce DJ
– volume: 25
  start-page: 530
  year: 1997
  ident: e_1_2_9_9_2
  article-title: Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo‐ and/or bromodeoxyuridine
  publication-title: Exp Hematol
  contributor:
    fullname: Raza A
SSID ssj0035032
Score 2.4694908
Snippet Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By...
Mass cytometry is a recently introduced technology that utilizes transition element isotope-tagged antibodies for protein detection on a single-cell basis. By...
Abstract Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 552
SubjectTerms Animals
Antibodies
Antibodies - chemistry
Bone Marrow Cells - metabolism
Bone Marrow Cells - physiology
cell cycle
Cell Cycle Checkpoints
Cell Differentiation
Cell Line
Cell Proliferation
Cell Separation
Cyclin A - metabolism
Cyclin B1 - metabolism
DNA Replication
Flow Cytometry
Hematopoiesis
Histones - metabolism
Humans
Immunophenotyping
iododeoxyuridine
mass cytometry
Membrane Proteins - metabolism
Mice
retinoblastoma
Retinoblastoma Protein - metabolism
Single-Cell Analysis - methods
Staining and Labeling
T-Lymphocytes - metabolism
T-Lymphocytes - physiology
Transition Elements - chemistry
Title Single‐cell mass cytometry adapted to measurements of the cell cycle
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.22075
https://www.ncbi.nlm.nih.gov/pubmed/22693166
https://search.proquest.com/docview/1022259224
https://search.proquest.com/docview/1492637283
Volume 81A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFA4iCF7cl3Ejgt7s6GRrexRxcEEFF9BTyHrRmYrTOYwnf4K_0V_iS9oZNxD01kKS5vVL8r48ku8htEWFbdmUqMSyVpYw7XmSZTZNFMDvnUqtiLkOz87F0Q07ueW3dcAt3IWp9CFGAbcwM-J6HSa40r3dD9FQMyiLpmoSAk4PluCgpRc40eVIPYryvZifLIiMJSwnpD73DtV3P1f-6pF-0MyvrDW6nfY0ksMOV6dN7pv9UjfN8zctx_9bNIOmakaK96shNIvGXHcOTVQ5KgfzqH0Fzu3Bvb28hhg_7gDZxqGJjiufBlhZ9QicFZcF7nxEG3u48BiYJY5VzADaXUA37cPrg6OkTr6QGJYSDmBpLjJlOc2NYNwym1NrnM28yjWlwhtNuSWaKOdSI2Cx8mLPe-5SDe_gGhfReLfoumWEhTLUEKGI9p4RprV1QFKEsiFtFmxXGmh7CIB8rDQ2ZKWmTGQwSCoZ_0kDbQ7RkTAJggmq64p-T1bbVoCY_VImSCPSFOhUAy1V0I6-Bhw0py0hGmgnAvRrN-TB3fVFfFr5W_FVNAl0qz7su4bGy6e-WwdKU-oNGLjHpxtx-L4DAv_0fg
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LTtwwFL1qqVC7gUIfTF-4Et01A-NXkiWiHU1bHhIdJLoyfm7KTBBkFsOqn8A38iW9djIDtBJS1V0i2Y6d4-t7fGWfC7DBpOu5nOrM8V6RcRNEVhQuzzTCH7zOnUy5Dvf25eCIfz0Wx22e03gXptGHmAfcomWk9ToaeAxIb96ohtppXXV1l1L0eg_hEVq8iJb56XCuH8XEVspQFmXGMl5S2p58x_qbt2vf9Ul_Ec27vDU5nv4ynMy63Jw3-dmd1KZrL_9Qc_yPMT2FpZaUku1mFq3AAz9ehcUmTeX0GfS_o3879de_rmKYn4yQb5PYxMjX51OinT5D2krqioxuAo4XpAoEySVJVewU230OR_3Pw51B1uZfyCzPqUC8jJCFdoKVVnLhuCuZs94VQZeGMRmsYcJRQ7X3uZW4XgW5FYLwucF39I4vYGFcjf0aEKkts1RqakLglBvjPPIUqV3MnIU7lg58mCGgzhqZDdUIKlMVB6S0Sv-kA-9n8Ci0gzgEPfbV5EI1O1fEmN9TJqojshwZVQdeNtjOv4Y0tGQ9KTvwMSF0bzfUzo_hQXp69W_F1-HxYLi3q3a_7H97DU-QfbVnf9_AQn0-8W-R4dTmXZrFvwGFTvel
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bTxQxFD4RjMQXvKCyglITeWMWtreZeTTABhHQCCT41PT6IruzgdmH5cmf4G_0l3DamV1EExJ4m0naTs98bc_Xk_Y7AB-ZdD2XU5053isyboLIisLlmUb4g9e5kynX4eGR3Dvl-2firA24xbswjT7ELOAWZ0Zar-MEH7mweSMaaid11dVdStHpzcFjLhmNm6-d7zP5KCa2UoKyqDKW8ZLS9uA71t_8u_Ztl_Qfz7xNW5Pf6T8DNe1xc9zkZ3dcm669-kfM8eEmPYfFlpKST80YegGP_PAlPGmSVE6WoH-M3u3c__n1Owb5yQDZNolNDHx9MSHa6RGSVlJXZHATbrwkVSBILUmqYifY7is47e-ebO9lbfaFzPKcCkTLCFloJ1hpJReOu5I5610RdGkYk8EaJhw1VHufW4mrVZBbIQifG3xH3_ga5ofV0C8DkdoyS6WmJgROuTHOI0uR2sW8Wbhf6cD6FAA1akQ2VCOnTFU0SGmV_kkHPkzRUTgLogl66KvxpWr2rQgxv6NM1EZkOfKpDrxpoJ19DUloyXpSdmAjAXRnN9T2j5Ov6ent_YqvwcK3nb46-Hz0ZQWeIvVqD_6uwnx9MfbvkN7U5n0aw9exCPZU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single%E2%80%90cell+mass+cytometry+adapted+to+measurements+of+the+cell+cycle&rft.jtitle=Cytometry.+Part+A&rft.au=Behbehani%2C+Gregory+K.&rft.au=Bendall%2C+Sean+C.&rft.au=Clutter%2C+Matthew+R.&rft.au=Fantl%2C+Wendy+J.&rft.date=2012-07-01&rft.issn=1552-4922&rft.eissn=1552-4930&rft.volume=81A&rft.issue=7&rft.spage=552&rft.epage=566&rft_id=info:doi/10.1002%2Fcyto.a.22075&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_cyto_a_22075
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4922&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4922&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4922&client=summon